Remove Conference Remove Drug Development Remove Pharmaceuticals Remove Public Health
article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer.

BioTech 107
article thumbnail

FDA Gives Diabetes Treatments Low Priority

Insulin Nation

Even though health officials readily admit that diabetes is an urgent public health problem, a new diabetes medicine or device usually finds itself in ninth position on the FDA docket for a pre-market clearance. To understand why requires an understanding of the history of the FDA, and its limitations.